MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$9,552K
EPS
-$0.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
Total revenues
0
41,297
5,442
Research and development
3,434
5,592
8,597
General and administrative
6,492
4,300
4,174
Impairment of long-term asset
-
0
587
Severance and other employee costs
-
0
-
Restructuring
0
0
0
Total operating expenses
9,926
9,892
13,358
Loss from operations
-9,926
31,405
-7,916
Interest income
377
1,243*
532
Other income (expense), net
-3
-2*
2
Total other income, net
374
1,241
534
Net income (loss) before income taxes
-
32,646*
-7,382
Income tax expense
-
261*
0
Net loss and comprehensive loss
-9,552
32,385
-7,382
Basic EPS
-0.16
0.574
-0.13
Diluted EPS
-0.16
0.473
-0.13
Basic Average Shares
57,968,608
56,397,653
56,280,844
Diluted Average Shares
57,968,608
68,473,101
56,280,844
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$377K
(-49.05%↓ Y/Y)
Net loss and
comprehensive loss
-$9,552K
(-461.88%↓ Y/Y)
Total other income,
net
$374K
(-49.73%↓ Y/Y)
Other income
(expense), net
-$3K
(-175.00%↓ Y/Y)
Loss from operations
-$9,926K
(-306.14%↓ Y/Y)
Total operating
expenses
$9,926K
(-40.32%↓ Y/Y)
General and
administrative
$6,492K
(10.45%↑ Y/Y)
Research and development
$3,434K
(-67.82%↓ Y/Y)
Buy us a coffee
Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO)